The 12 closest competitors and alternatives to GENINCODE PLC among biotech companies — ranked by similarity to what GENINCODE PLC actually does, not by market-cap band.
Subscribe to see GENINCODE PLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
GENinCode Plc specializes in the creation and commercialization of advanced genetic tests designed to forecast potential health risks based on an individual's DNA. Operating in both the United Kingdom and internationally, their predictive technology empowers individuals and medical professionals alike with proactive health management and targeted intervention strategies. The company's sophisticated molecular diagnostics leverage a combination of clinical algorithms and artificial intelligence to deliver precise patient risk assessments, thereby anticipating the onset of various diseases. Among their specialized tests are: Cardio inCode: A patented genetic assay designed to guide individuals in cardiovascular prevention. Lipid inCode: A genetic diagnostic tool that analyzes seven specific genes associated with familial hypercholesterolemia. SUDD inCode: A genetic test to identify the underlying causes of sudden cardiac death and inherited heart conditions. Thrombo inCode: This test assesses 12 genetic variants linked to hereditary thrombophilia and the general risk of thrombosis (blood clots). Thrombo inCode Reproductive Health: Offering crucial insights into thrombophilia risks particularly relevant to prospective pregnancies. Established in 2018, GENinCode Plc maintains its headquarters in Oxford, United Kingdom.
GENINCODE PLC is a biotech company headquartered in Oxford, United Kingdom, founded in 2018. Xcout tracks 10 named people at GENINCODE PLC, including Bryan David Castellani (CFO & Director).
4 more named people on record for GENINCODE PLC, with roles, board committees and tenure — see the full roster →
Ranked by semantic similarity — how close each company is to GENINCODE PLC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Identifai Genetics is a clinical-stage biotechnology and health tech company developing advanced prenatal screening tests using AI, machine learning, and whole genome analysis. It is headquartered in Rosh Haayin, Israel.
Biotechnology
PhiTech is a TechBio biotechnology company headquartered in Gebze, Kocaeli, Turkey. The firm leads a global shift from DNA-only diagnostics to AI-powered multi-omics, establishing new standards for precision medicine. Utilizing advanced bioinformatics and decision analysis, the company develops cutting-edge diagnostic tools.
Similar biotech company
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Healthcare
Inocras Inc. is a bioinformatics-led biotechnology company headquartered in San Diego, California. The firm utilizes whole genome data and proprietary artificial intelligence analytics to deliver curated genomic care.
Health Learning
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
Similar biotech company
Health in Code is a Spanish company that provides genetic and genomic diagnostic services, including sequencing, bioinformatics, and clinical interpretation. It serves hospitals, clinical laboratories, healthcare professionals, and patients, with a focus on hereditary and rare diseases such as inherited cardiovascular conditions.
Similar biotech company
Nightingale Health Plc provides advanced health check and remote health check products designed for the healthcare, insurance, government, and consumer health sectors. The company also offers proprietary 'omics technology and preventive screening solutions to support medical research and disease risk detection.
Biotechnology
gMendel is a medical technology company founded in 2020 that develops an AI-powered, cloud-based platform combining genomics with artificial intelligence. The company provides decision support software designed to enable faster, more accurate, and scalable diagnosis of genetic disorders.
Similar biotech company
Oxford BioDynamics Plc operates as a biotechnology firm that specializes in identifying and advancing biomarkers, primarily for the pharmaceutical and biotechnology sectors across global markets, including the United States. Its flagship offering is EpiSwitch, an exclusive technological platform employed for discovering, assessing, validating, and tracking epigenetic biomarkers, specifically referred to as chromosome conformation signatures. These are crucial for developing medical diagnostic kits, predicting disease onset, aiding in diagnosis, and informing therapeutic strategies. The company's key products encompass the EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a validated prognostic tool for forecasting patient responses to checkpoint inhibitor immunotherapy; the EpiSwitch CST (Covid Severity Test), a sophisticated blood test designed to predict the severity of COVID-19 in adults; and the EpiSwitch Explorer Array Kit, which enables high-resolution 3D genome analysis and novel biomarker discovery. Established in 2007, Oxford BioDynamics Plc maintains its headquarters in Oxford, United Kingdom.
Biotechnology
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
Similar biotech company
Source BioScience is a UK-based laboratory services company providing genomics, DNA sequencing, molecular diagnostics, and pathology-related testing. It serves pharmaceutical and biotechnology companies, healthcare organizations, research institutions, and other life-science customers.
Similar biotech company
IntegraGen develops genomic tests, molecular diagnostic products, and bioinformatics software for researchers, clinicians, and biopharma companies. The company specializes in oncology and genetic diseases, offering next-generation sequencing services, data analysis tools, and biomarker identification to support clinical research and diagnostics.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for GENINCODE PLCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →